The aim of the study was to evaluate the long-term results of allograft and prosthetic valve replacement in the treatment of infective aortic valve endocarditis with periannular abscess. Between March 1988 and March 1996, 65 patients underwent surgery for active aortic valve endocarditis and paravalvular abscess. The indications for surgery were congestive heart failure, systemic emboli and atrioventricular block III. The pre-operative evaluation was performed with transoesophageal echocardiography. Aortic valve replacement was performed with allografts in 47 cases, with mechanical valves in 15, and bioprosthetic valves in three cases. All patients with total ventricularaortic dehiscence and prosthetic valve endocarditis were treated with allografts.
Introduction
Aortic root infection remains a challenging problem for the surgical treatment of native and prosthetic valve endocarditis. Its success depends on the location and extent of the abscess cavities. Particularly difficult to manage technically are multiple or large single annular abscesses that extend into the ventricular muscle to form left-right shunts or which destroy the mitral annulus. The major determinants for the successful surgical management of these cases are the complete exclusion of the abscess cavities from the circulation and the reconstruction of the cardiac structures after thorough debridement [1] . Several operative techniques to solve these problems have been proposed. This report summarizes our experience of the surgical treatment of patients with active infective aortic valve endocarditis with an associated periannular abscess over a period of 8 years.
Material and methods
From March 1986 through to March 1996, 65 consecutive patients with aortic valve endocarditis complicated by periannular abscess (out of 226 patients with acute aortic valve endocarditis) underwent surgery at our institution.
There were 56 male and nine female patients with ages that ranged from 18 to 75 years (mean 50·7 years). Forty-seven presented with native and 18 with prosthetic valve endocarditis. In eight cases aortic valve endocarditis was combined with mitral valve endocarditis. The diagnosis was based on clinical, microbiological and echocardiograhical findings. We defined active endocarditis in accordance with the Stanford criteria [2] : (1) clinical features of active endocarditis; (2) positive preoperative blood cultures; (3) intra-operative findings of active infection; and (4) proof of infection in the excised material by histological staining or cultures and, in addition, by echocardiographical findings.
All patients were examined by both transthoracic and transoesophageal echocardiography. On echocardiography an abscess was considered to be present when an irregular echo-dense or echo-lucent area [3, 4] of at least 2 mm in diameter within the valvular annulus or periannular myocardium was found; and/or a discontinuity of layers in the aortic root; and/or the presence of pathological aorticoatrial connections were found in colour Doppler and were confirmed by pulse wave Doppler scanning in a setting of valvular infection. These findings had to be present in at least two echocardiographic sections.
During surgery, an abscess was defined as a region of necrosis that contained purulent material which penetrated into the valvular annulus or the adjacent myocardial structures.
Indications for operation (Table 1)
The predominant indication for operation was congestive heart failure. Twenty-one patients (32·3%) were pre-operatively in New York Heart Association (NYHA) class III, 18 (27·7%) were in class IV, and 13 (20%) were in cardiogenic shock upon their admittance to our institution. Acute aortic valve insufficiency was frequently present in the patients with advanced stages of congestive heart failure, which resulted in equalization of left ventricular diastolic and aortic diastolic pressures with preclosure of the mitral valve. This situation was considered to be an indication for urgent operation. Eight patients (12·3%) suffered from one or more episodes of systemic embolizations pre-operatively (three cerebral, four peripheral and one coronary). Five patients (7·7%) had complete atrioventricular blockage. The presence of sepsis alone was not considered as an indication for operation.
Choice of the valve
Whenever periannular abscess was detected by echocardiography, we scheduled the patient for allograft aortic valve replacement. Only in cases of undetected annular abscess, or if an appropriate allograft was not available did we perform mechanical or bioprosthetic valve replacement. However, all patients with total ventricular-aortic dehiscence and prosthetic valve endocarditis were treated with allografts in this study.
Microbiology
The causative microorganisms were identified in preoperative blood cultures or in operative specimens in 87·7% of the patients (Table 2 ). Staphylococci were the commonest valvular pathogen (40%) and streptococci were the second most frequently detected infectious agent (35·4%).
Localization of abscess cavities (Table 3)
The abscess cavities were most commonly located in the non-coronary (nine cases) and the left coronary sinus (eight cases). The subannular interventricular septum was involved in 13 cases (18·6%). One patient had an aneurysm of the sinus of Valsalva. Complete aorticoventricular dehiscence was found in 10 patients (15·7%).
Operative techniques
Surgery was performed via median sternotomy with the use of extracorporal circulation, moderate systemic 
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Eur Heart J, Vol. Table 4 . In all cases the abscess was carefully irrigated and disinfected intra-operatively with a 2·5% povidone-iodine solution. The major principle in the treatment of aortic valve endocarditis with periannular abscess was to reconstruct the aortic root either by subcoronary replacement in such a way so as to exclude the abscess cavities from the circulation after thorough debridement or, in cases with defects localized at the aortic-mitral septum, total aortic root replacement with reimplantation of the coronary arteries. When feasible, the retained anterior leaflet of the mitral valve was used to repair the periannular defects ( Fig. 1) . Sizing of the valve annulus was determined pre-operatively by echocardiography and confirmed during surgery.
Subcoronary implantation of the freehand allograft valve was performed by the method developed by Ross where the non-coronary sinus was preserved [5] . The proximal suture line was undertaken with 4-0 polypropylene single-mattress sutures with equine pericard pledgets. In advanced aortic root abscess formation and ventricular-aortic discontinuity, allograft root replacement with reimplantation of the coronary arteries was performed by the use of the technique described by Ross [6] . In this series ABO blood group compatible allografts were used. The mechanical or bioprosthetic valves were always inserted with interrupted sutures reinforced with glutaraldehyde-treated equine pericard pledgets. In two patients of this group equine pericardial patches were required for the closure of large abscess cavities. In three cases the aortic valve endocarditis was associated with a mycotic aortic aneurysm of the ascending aorta. In these instances the operations were accomplished by concomitant replacement of the aortic root and the ascending aorta [7] . In eight cases the endocarditis involved the mitral valve, which necessitated mitral valve replacement. Jet lesions of the anterior mitral valve leaflet were reconstructed by pericardial patch in three cases. Additional procedures were tricuspid valve repair or coronary artery bypass grafting in the case of associated coronary artery disease or septic coronary embolization (Table 2) .
Postoperatively complete atrioventricular blockage was observed in seven patients. In five of them the atrioventricular block was the indication for operation. All patients were treated with appropriate parenteral antibiotics for at least 6 weeks starting from the date of operation.
Cryopreservation of allografts
The allografts were harvested during heart transplantation and from multiorgan donations [8] . Graft preparation included sterile procurement and storage at 4 C in a preservation fluid with antibiotics according to the method of Yankah and Hetzer [9] . In brief, within 24 h of storage, the allografts were placed in a fresh antibiotic medium supplemented with 10% dimethyl sulfoxide (DMSO; Fisher Scientific Co., Pittsburgh, PA, U.S.A.). The grafts were then cryopreserved with a computercontrolled rate freezer that lowered the temperature 1 C 
LV-Ao-dehiscence 11 0 11 15·7 
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per minute down to a temperature of 40 C. The specimens were then placed in the vapour phase of a liquid nitrogen freezer or at 80 C in a refrigerator located in the operating theatre.
Follow-up data were obtained in the survivors through either personal communication or the house physician, for periods that ranged from 3 to 12 years.
Statistical analysis
Rates of survival, of freedom from reinfection and of freedom from reoperation estimates were computed using the Kaplan-Meier product-limit method [10] .
Results

Echocardiographic diagnosis
Sensitivity and specificity for detection of abscesses associated with aortic valve endocarditis by transoesophageal echocardiography were 87·6% and 96·9% respectively.
Survival Early death
The 30-day mortality rate was 8·5% in the allograft and 23·5% in the prosthetic group. Pre-operative cardiogenic shock and sepsis were the risk factors for early death.
Late death
Late deaths occurred in four patients after allograft replacement, which resulted in a 1 and an 11 year survival rate of 89·3% and 82·1%, respectively (Fig. 2 ). There were two sudden deaths. One occurred 2 months after surgery, and another 3 years after surgery. Two patients died during reoperation. This was performed in one patient suffering from severe intravenous drug abuse, with recurrent infection 51 months after operation, and in another for early degeneration of the allograft valve 33 months after the first operation. In the prosthetic group, late death was related to reoperation for recurrent infection during the first year after operation, which resulted in an actuarial 1 and 11 year survival of 64·7% and 64·7%, respectively.
Recurrent infection
Recurrent endocarditis was observed in three patients after prosthetic valve replacement. As a result, the actuarial freedom from reinfection was 83·3% after 1 year and 72·1% after 11 years (Fig. 3) . In the group of patients treated with an allograft we observed one patient who, suffering from severe intravenous drug abuse, developed aortic valve endocarditis 51 months after allograft replacement, which necessitated reoperation.
Reoperation
In the prosthetic group, recurrent endocarditis was found in two patients, which occurred between 7 and 9 months after the initial operation. One patient developed prosthetic valve endocarditis 7·5 years after surgery which necessitated reoperation (Fig. 4) . In the allograft group four patients underwent reoperation. The causes for reoperation were paravalvular leaks with pseudoaneurysm in two patients (2 and 18 months after operation), an early degeneration of the allograft valve in one patient and a recurrent endocarditis in one as mentioned above. Echo Doppler studies, which were performed at 1 year intervals postoperatively in all other allograft group patients showed no gradient greater than 5 mmHg and no regurgitation greater than I (scale I-IV).
Discussion
The surgical treatment of active aortic valve endocarditis was introduced in the early years of open heart surgery [11] . With increasing experience and the improvement of myocardial protection, timely valve replacement has been shown to lead to an excellent outcome. However, aortic valve endocarditis with associated periannular abscess still remains a surgically challenging disease with significantly increased mortality and rate of recurrent infection. Early diagnosis of periannular abscess and early surgical treatment is essential in the prevention of severe annular destruction [12] . In several studies, pre-operative transoesophageal echocardiography has proved to be a valuable and useful technique for the early diagnosis of periannular involvement [3, 4] . In our experience it is the most important diagnostic tool in pre-operative decision making.
Aortic root infection occurs in one-third of all patients with native valve endocarditis and in one half of patients with prosthetic valve endocarditis [13] . In the case of native valve endocarditis, the infection primarily involves the valve leaflet. In patients with prosthetic valve endocarditis, the prosthesis infection originates at the sewing ring and extends along the sutures into the annulus. The ongoing infection extends to the annulus and the adjacent structures. This pathophysiological difference may explain in part the high mortality rate associated with prosthetic valve endocarditis and periannular abscess [14] . The major determinant for the successful management of these cases is complete exclusion of the abscess cavities from the circulation. Several surgical techniques for repairing the infected aortic root have been used, such as patch closure of the abscess and in situ valve replacement in three patients reported by Symbas et al. [15] , translocation of the aortic valve with closure of the native coronary ostia and saphenous vein bypass grafts to the coronary arteries on four patients (with success in three) reported by Reitz and colleagues [16] , or prosthetic valve/Dacron composite graft reconstruction used by Frantz et al. [17] In spite of the successful use of these techniques in selected cases, the covering of abscesses with pericardial or Dacron patches leaves infected material in situ, which risks recurrent infection and the development of periprosthetic leaks. In the last few years there have been reports that advocate the use of an ABF glue compound as an efficient prophylactic tool, which prevents postoperative residual endocarditis [18] . In comparison with mechanical or bioprosthetic valves, allografts have a theoretical and practical advantage, which is associated with their resistance to infection, flexibility and additional periannular tissue, such as the muscular cuff and the anterior leaflet of the mitral valve [19, 21] . This may explain the better early results of allografts when compared with prosthetic or bioprosthetic valves in our study. Glazier and co-workers reported that from 30 patients, who underwent allograft 
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insertion for complicated prosthetic valve endocarditis with subannular abscesses, two of the 21 survivors developed recurrent endocarditis [22] . Bedi and Farnesworth reported prosthetic valve endocarditis with extensive destruction of the aortic root, annular abscess formation and left ventriculoaortic discontinuity in three patients with aorta-to-left-artrial fistula formation in two of these [23] . All three patients were treated successfully with allograft root replacement by the use of the anterior mitral leaflet of the aortic root to repair the fistula without recurrent endocarditis.
The data from this study confirms the findings of McGriffin et al. [24] , that the risk of recurrent valve infection with a bioprosthesis or a mechanical prosthesis is highest early after surgery and then reaches a level of constant hazard. In contrast, the allograft valve, has a low constant hazard level without early increased risk after surgery. However, these are not multivariate analysed data; the difference in the hazard curves suggests an intrinsic resistance of the allograft to infection.
Since the introduction of allograft valves for aortic valve replacement by Ross, the free-hand insertion technique has become the more routine method of replacement. However, recently published studies [25] show that the intra-aortic cylinder technique or total root replacement result in a more reliable reconstruction and valve function. This may be of particular importance in destructive aortic root infection. Therefore, in those cases of extensive annular destruction with partial or complete aortic-left ventricular dehiscence, we employed allograft root replacement. In the case of associated mycotic aneurysm of the ascending aorta, we performed allograft root and ascending aorta replacement as a composite graft [7] . Recently, Petterson et al. [26] and Oswalt et al. [27] reported impressive results with the use of pulmonary autografts for the treatment of acute valve endocarditis. This did not seem not to be feasible in our patients who presented in advanced stages of heart failure on admission to our institution. Nevertheless, the patients in this study were not randomly assigned to the treatment groups. The fact that all patients with prosthetic valve infection and all cases of advanced periannular abscess with partial or complete aortic-ventricular dehiscence were treated by allograft replacement underlines their higher efficacy in infection control and higher resistance to reinfection when compared with prosthetic grafts.
This study confirms, in a large series of patients, the contention that the use of allograft valves should be the treatment of choice in cases of infective aortic valve endocarditis with associated periannular abscess. The operative mortality and the recurrence rate of infection are lower than in the group with prosthetic valve replacement. Diagnosis and surgical management of complicated aortic valve endocarditis should be based on preoperative transesophageal echocardiography, which has proved to be a very reliable diagnostic tool. 
